JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
02/10/26 - 14:22
Margherita Sacerdoti appointed Investor Relations & ESG Senior Director at Diasorin (151.77 KB)
04/05/26 - 17:45
Diasorin Strengthens its Leadership of Immuno Division with the Appointment of Gabriele Allegri as President (158.42 KB)
29/04/26 - 15:52
Shareholders' Meeting 2026 (166.06 KB)
07/04/26 - 10:05
Communication on total amount of voting rights (7 April 2026) (225.44 KB)
19/03/26 - 9:47
Diasorin signs strategic distribution agreement with McKesson Medical Surgical to expand access for the LIAISON NES molecular point‑of‑care platform (234.16 KB)
27/01/26 - 16:05
The Shareholders' meeting authorized the purchase of treasury shares, approved the amendment of art. 5 of the articles of association and authorized the cancellation of treasury shares. The Board approved the launch of the buyback plan. (120.91 KB)
23/01/26 - 17:49
Succession in the role of Group Chief Financial Officer of Diasorin. Alberto Donati appointed new Group Chief Financial Officer. (108.99 KB)
24/10/23 - 15:03
Diasorin unveils its new Corporate identity and launches the new Group website: www.diasorin.com (574.08 KB)
27/07/23 - 14:27
Update 2023 Annual Calendar of Corporate Events (104.1 KB)
03/07/23 - 11:48
Suspension of the effectiveness of the disqualifying accessory administrative sanction imposed by CONSOB to the Chief Executive Officer Mr. Carlo Rosa (102.52 KB)
05/06/23 - 21:58
Administrative sanctions imposed by CONSOB in connection with the alleged breach to disclose obligations relating to inside information. Action for annulment. (107.91 KB)
28/04/23 - 12:52